Upregulation of ADAM19 in chronic allograft nephropathy

American Journal of Transplantation

Volumn 6, Issue 7, 2006, Pages 1673-1681

  Melenhorst, W B W H ^a   Van Den Heuvel, M C ^a   Stegeman, C A ^a   Van Der Leij, J ^a   Huitema, S ^a   Van Den Berg, A ^a   Van Goor, H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

ADAM; ADAM19; Allograft nephropathy; Interstitial fibrosis; Meltrin beta; Metalloproteinase

Indexed keywords

MESSENGER RNA; METALLOPROTEINASE; PROTEIN ADAM19; RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELL INTERACTION; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; ENDOTHELIUM; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INFLAMMATION; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISTAL TUBULE; KIDNEY FIBROSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE;

ADAM PROTEINS; ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; CHRONIC DISEASE; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEPHROSIS; RNA, MESSENGER; TRANSPLANTATION, HOMOLOGOUS; UP-REGULATION;

EID: 33745420567     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01384.x     Document Type: Article

References (33)

1. Kreis HA Ponticelli C. Causes of late renal allograft loss: Chronic allograft dysfunction, death, and other factors. Transplantation 2001 71 ( 11 Suppl SS5 SS9.
2. Joosten SA Sijpkens YW van Kooten C Paul LC. Chronic renal allograft rejection: Pathophysiologic considerations. Kidney Int 2005 68 : 1 13.
3. Blobel CP. Metalloprotease-disintegrins: Links to cell adhesion and cleavage of TNF alpha and Notch. Cell 1997 90 : 589 592.
4. Stone AL Kroeger M Sang QX. Structure-function analysis of the ADAM family of disintegrin-like and metalloproteinase-containing proteins (review). J Protein Chem 1999 18 : 447 465.
5. Wolfsberg TG Primakoff P Myles DG White JM. ADAM, a novel family of membrane proteins containing A Disintegrin and Metalloprotease domain: Multipotential functions in cell-cell and cell-matrix interactions. J Cell Biol 1995 131 : 275 278.
6. Blobel CP. Remarkable roles of proteolysis on and beyond the cell surface. Curr Opin Cell Biol 2000 12 : 606 612.
7. Primakoff P Myles DG. The ADAM gene family: Surface proteins with adhesion and protease activity. Trends Genet 2000 16 : 83 87.
8. Fritsche J Moser M Faust S et al. Molecular cloning and characterization of a human metalloprotease disintegrin-a novel marker for dendritic cell differentiation. Blood 2000 96 : 732 739.
9. Wei P Zhao YG Zhuang L Ruben S Sang QX. Expression and enzymatic activity of human disintegrin and metalloproteinase ADAM19/meltrin beta. Biochem Biophys Res Commun 2001 280 : 744 755.
10. Chesneau V Becherer JD Zheng Y Erdjument-Bromage H Tempst P Blobel CP. Catalytic properties of ADAM19. J Biol Chem 2003 278 : 22331 22340.
11. Fata JE Kong YY Li J et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 2000 103 : 41 50.
12. Kong YY Yoshida H Sarosi I et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999 397 : 315 323.
13. Lacey DL Timms E Tan HL et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998 93 : 165 176.
14. Zheng Y Saftig P Hartmann D Blobel C. Evaluation of the contribution of different ADAMs to TNFa shedding and of the function of the TNFa ectodomain in ensuring selective stimulated shedding by the TNFa convertase (TACE/ADAM17). J Biol Chem, 2004 279 : 42898 42906.
15. Lautrette A Li S Alili R et al. Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: A new therapeutic approach. Nat Med 2005 11 : 867 874.
16. Roemer A Schwettmann L Jung M et al. The membrane proteases adams and hepsin are differentially expressed in renal cell carcinoma. Are they potential tumor markers? J Urol 2004 172 : 2162 2166.
17. Roemer A Schwettmann L Jung M et al. Increased mRNA expression of ADAMs in renal cell carcinoma and their association with clinical outcome. Oncol Rep 2004 11 : 529 536.
18. Shirakabe K Wakatsuki S Kurisaki T Fujisawa-Sehara A. Roles of Meltrin beta/ADAM19 in the processing of neuregulin. J Biol Chem 2001 276 : 9352 9358.
19. Horiuchi K Zhou HM Kelly K Manova K Blobel CP. Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins beta1 and beta2. Dev Biol 2005 283 : 459 471.
20. Zhou HM Weskamp G Chesneau V et al. Essential role for ADAM19 in cardiovascular morphogenesis. Mol Cell Biol 2004 24 : 96 104.
21. Kurohara K Komatsu K Kurisaki T et al. Essential roles of Meltrin beta (ADAM19) in heart development. Dev Biol 2004 267 : 14 28.
22. Racusen LC Solez K Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999 55 : 713 723.
23. van den Berg A Visser L Poppema S. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. Am J Pathol 1999 154 : 1685 1691.
24. van der Leij J van den Berg A Albrecht EW et al. High expression of TIAF-1 in chronic kidney and liver allograft rejection and in activated T-helper cells. Transplantation 2003 75 : 2076 2082.
25. Inkinen KA Soots AP Krogerus LA Lautenschlager IT Ahonen JP. Fibrosis and matrix metalloproteinases in rat renal allografts. Transpl Int 2005 18 : 506 512.
26. Gould RJ Polokoff MA Friedman PA et al. Disintegrins: A family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med 1990 195 : 168 171.
27. Zhang XP Kamata T Yokoyama K Puzon-McLaughlin W Takada Y. Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin alphavbeta3. J Biol Chem 1998 273 : 7345 7350.
28. Eto K Puzon-McLaughlin W Sheppard D Sehara-Fujisawa A Zhang XP Takada Y. RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction. J Biol Chem 2000 275 : 34922 34930.
29. Mishra R Leahy P Simonson MS. Gene expression profiling reveals role for EGF-family ligands in mesangial cell proliferation. Am J Physiol Renal Physiol 2002 283 : F1151 F1159.
30. Terzi F Burtin M Hekmati M et al. Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury. J Clin Invest 2000 106 : 225 234.
31. Hernandez-Fuentes MP Baker RJ Lechler RI. The alloresponse. Rev Immunogenet 1999 1 : 282 296.
32. Krause SW Rehli M Kreutz M Schwarzfischer L Paulauskis JD Andreesen R. Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol 1996 60 : 540 545.
33. Perri RT Kay NE McCarthy J Vessella RL Jacob HS Furcht LT. Fibronectin enhances in vitro monocyte-macrophage-mediated tumoricidal activity. Blood 1982 60 : 430 435.